NORFLOXACIN - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for norfloxacin and what is the scope of patent protection?

Norfloxacin is the generic ingredient in two branded drugs marketed by Merck and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for norfloxacin.

Summary for NORFLOXACIN

US Patents:	0
Tradenames:	2
Applicants:	1
NDAs:	2
Drug Master File Entries:	7
Raw Ingredient (Bulk) Api Vendors:	144
Clinical Trials:	24
Patent Applications:	6,967
DailyMed Link:	NORFLOXACIN at DailyMed

Recent Clinical Trials for NORFLOXACIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ospedali Riuniti di Foggia	Phase 3
Samar Atef Sebaweh Mohammed	Phase 2
Institute of Liver and Biliary Sciences, India	N/A

See all NORFLOXACIN clinical trials

Medical Subject Heading (MeSH) Categories for NORFLOXACIN

Anti-Bacterial Agents
Cytochrome P-450 CYP1A2 Inhibitors
Topoisomerase II Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for NORFLOXACIN

J01MA	Fluoroquinolones
J01M	QUINOLONE ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

S01AE	Fluoroquinolones
S01A	ANTIINFECTIVES
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for NORFLOXACIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Merck	NOROXIN	norfloxacin	TABLET;ORAL	019384-002	Oct 31, 1986		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Merck	CHIBROXIN	norfloxacin	SOLUTION/DROPS;OPHTHALMIC	019757-001	Jun 17, 1991		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NORFLOXACIN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck	CHIBROXIN	norfloxacin	SOLUTION/DROPS;OPHTHALMIC	019757-001	Jun 17, 1991	⤷ Sign Up	⤷ Sign Up
Merck	NOROXIN	norfloxacin	TABLET;ORAL	019384-002	Oct 31, 1986	⤷ Sign Up	⤷ Sign Up
Merck	NOROXIN	norfloxacin	TABLET;ORAL	019384-002	Oct 31, 1986	⤷ Sign Up	⤷ Sign Up
Merck	CHIBROXIN	norfloxacin	SOLUTION/DROPS;OPHTHALMIC	019757-001	Jun 17, 1991	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.